Skip to main content
COR logo

COR · Cencora, Inc. · Webcasts, Transcripts & Audio

Track COR — free
Market Cap
$65.12B
Shares
190.83M
Volume · Nov 19 1.5M Avg daily vol (3M) 1.28M

Cencora, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Cencora, Inc. (COR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q4
2026-11-04
Cencora, Inc. (COR) Q4 2026 Earnings Call Transcript
Confident tone MSO acquisitions and physician expansion Fiscal 2027 consolidated guidance Specialty growth platform
Results not yet reported
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-09-15
Cencora, Inc. (COR) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-15
Cencora, Inc. (COR) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-08
Cencora, Inc. (COR) September 8, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-08-05
Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript
Confident tone Specialty pharmaceutical platform and growth Talent and leadership transitions International / European distribution strength
Revenue
$84.75B
▲ 5.1% YoY
Diluted EPS
$3.94
▲ 11.9% YoY
Gross margin
4.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-05-13
Cencora, Inc. (COR) May 13, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-05-06
Cencora, Inc. (COR) Q2 2026 Earnings Call Transcript
Positive tone Specialty pharmaceuticals and MSO platform EPS growth and fiscal 2026 guidance Capital deployment and share repurchases
Revenue
$78.36B
▲ 3.8% YoY
Diluted EPS
$8.40
▲ 128.3% YoY
Gross margin
4.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-10
Cencora, Inc. (COR) March 10, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-02-04
Cencora, Inc. (COR) Q1 2026 Earnings Call Transcript
Confident tone MSO expansion and acquisitions Guidance raise Specialty pharmaceuticals leadership
Revenue
$85.93B
▲ 5.5% YoY
Diluted EPS
$2.87
▲ 14.8% YoY
Gross margin
3.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-11-05
Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript
Confident tone Strategic portfolio review / divestitures Capital deployment Specialty growth and positioning
Revenue
$83.73B*
▲ 5.9% YoY
Gross margin
3.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-08-06
Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript
Positive tone Specialty Pharmaceuticals and RCA GLP-1 Profitability Outlook Pharmaceutical Distribution and DSCSA
Revenue
$80.66B
▲ 8.7% YoY
Diluted EPS
$3.52
▲ 45.5% YoY
Gross margin
3.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-05-07
Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript
Confident tone Specialty Pharmaceuticals & Global Leadership MSOs / M&A (One Oncology, RCA) Guidance Raise & EPS Growth
Revenue
$75.45B
▲ 10.3% YoY
Diluted EPS
$3.68
▲ 76.1% YoY
Gross margin
4.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-02-05
Cencora, Inc. (COR) Q1 2025 Earnings Call Transcript
Confident tone Specialty growth and acquisitions COVID vaccine headwind World Courier / clinical trial softness
Revenue
$81.49B
▲ 12.8% YoY
Diluted EPS
$2.50
▼ 16.1% YoY
Gross margin
3.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-11-06
Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript
Positive tone RCA Acquisition and Specialty Expansion CEO Transition IRA and Regulatory Policy
Revenue
$79.05B*
▲ 14.7% YoY
Gross margin
3.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-07-31
Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript
Confident tone Quarterly financial performance and raised outlook Good Neighbor Pharmacy and ThoughtSpot Pharmaceutical-centric strategy and integrated solutions
Revenue
$74.24B
▲ 10.9% YoY
Diluted EPS
$2.42
▲ 3% YoY
Gross margin
3.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-05-01
Cencora, Inc. (COR) Q2 2024 Earnings Call Transcript
Confident tone Financial results and EPS growth CEO succession Pharmaceutical manufacturers and commercialization services
Revenue
$68.41B
▲ 7.8% YoY
Diluted EPS
$2.09
▼ 1.9% YoY
Gross margin
3.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-01-31
Cencora, Inc. (COR) Q1 2024 Earnings Call Transcript
Confident tone Full-Year Guidance Raise GLP-1 Demand and Growth International Segment and Egypt Headwind
Revenue
$72.25B
▲ 15% YoY
Diluted EPS
$2.98
▲ 27.9% YoY
Gross margin
3.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-11-02
Cencora, Inc. (COR) Q4 2023 Earnings Call Transcript
Revenue
$68.92B*
▲ 12.7% YoY
Gross margin
3.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-08-02
Cencora, Inc. (COR) Q3 2023 Earnings Call Transcript
Revenue
$66.95B
▲ 11.5% YoY
Diluted EPS
$2.35
▲ 22.4% YoY
Gross margin
3.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-05-02
Cencora, Inc. (COR) Q2 2023 Earnings Call Transcript
Revenue
$63.46B
▲ 9.9% YoY
Diluted EPS
$2.13
▼ 17.8% YoY
Gross margin
3.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-02-01
Cencora, Inc. (COR) Q1 2023 Earnings Call Transcript
Revenue
$62.85B
▲ 5.4% YoY
Diluted EPS
$2.33
▲ 9.4% YoY
Gross margin
3.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-11-03
Cencora, Inc. (COR) Q4 2022 Earnings Call Transcript
Revenue
$61.17B*
▲ 3.8% YoY
Gross margin
3.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-08-03
Cencora, Inc. (COR) Q3 2022 Earnings Call Transcript
Revenue
$60.06B
▲ 12.5% YoY
Diluted EPS
$1.92
▲ 37.1% YoY
Gross margin
3.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-05-04
Cencora, Inc. (COR) Q2 2022 Earnings Call Transcript
Revenue
$57.72B
▲ 17.4% YoY
Diluted EPS
$2.59
▲ 23.3% YoY
Gross margin
3.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-02-02
Cencora, Inc. (COR) Q1 2022 Earnings Call Transcript
Revenue
$59.63B
▲ 13.5% YoY
Diluted EPS
$2.13
▲ 17.7% YoY
Gross margin
3.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-11-04
Cencora, Inc. (COR) Q4 2021 Earnings Call Transcript
Revenue
$58.91B*
▲ 19.6% YoY
Gross margin
3.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-08-04
Cencora, Inc. (COR) Q3 2021 Earnings Call Transcript
Revenue
$53.41B
▲ 17.7% YoY
Diluted EPS
$1.40
▼ 0.7% YoY
Gross margin
3.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-05-05
Cencora, Inc. (COR) Q2 2021 Earnings Call Transcript
Revenue
$49.15B
▲ 3.7% YoY
Diluted EPS
$2.10
▼ 54.7% YoY
Gross margin
3.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-02-04
Cencora, Inc. (COR) Q1 2021 Earnings Call Transcript
Revenue
$52.52B
▲ 9.7% YoY
Diluted EPS
$1.81
▲ 101.1% YoY
Gross margin
2.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-11-05
Cencora, Inc. (COR) Q4 2020 Earnings Call Transcript
Revenue
$49.24B
▲ 7.9% YoY
Diluted EPS
$-23.74
▼ 3868.3% YoY
Gross margin
2.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-08-05
Cencora, Inc. (COR) Q3 2020 Earnings Call Transcript
Revenue
$45.37B
▲ 0.3% YoY
Diluted EPS
$1.41
▼ 1.4% YoY
Gross margin
2.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-05-07
Cencora, Inc. (COR) Q2 2020 Earnings Call Transcript
Revenue
$47.42B
▲ 9.5% YoY
Diluted EPS
$4.64
▲ 3469.2% YoY
Gross margin
2.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-01-30
Cencora, Inc. (COR) Q1 2020 Earnings Call Transcript
Revenue
$47.86B
▲ 5.4% YoY
Diluted EPS
$0.90
▼ 51.1% YoY
Gross margin
2.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–33 of 33 webcasts
Key facts CIK 1140859 CUSIP 03073E105 13F (30d) 1274 filings 1159 filers Visit website Investor relations